Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease

被引:106
|
作者
Hauptmann, Susanne [1 ]
Keil, Uta
Scherping, Isabel
Bonert, Astrid
Eckert, Anne
Mueller, Walter E.
机构
[1] Goethe Univ Frankfurt, Dept Pharmacol, Bioctr, D-60439 Frankfurt, Germany
[2] Univ Basel, Psychiat Clin, Neurobiol Res Lab, CH-4025 Basel, Switzerland
关键词
Alzheimer's disease; mitochondrial dysfunction; beta-amyloid; neurofibrillary tangles;
D O I
10.1016/j.exger.2006.03.012
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Increasing evidence suggests an important role of mitochondrial dysfunction in the pathogenesis of many common age-related neurodegenerative diseases, including Alzheimer's disease (AD). AD is the most common neurodegenerative disorder characterized by dementia, memory loss, neuronal apoptosis and eventually death of the affected individuals. AD is characterized by two pathologic hallmark lesions that consist of extracellular plaques of amyloid-beta peptides and intracellular neurofibrillary tangles composed of hyperphosphorylated microtubular protein tau. Even though the idea that amyloid beta peptide accumulation is the primary event in the pathogenesis of Alzheimer's disease has become the leading hypothesis, the causal link between aberrant amyloid precursor protein and tau alterations in this type of dementia remains controversial. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:668 / 673
页数:6
相关论文
共 50 条
  • [21] Role of mitochondrial dysfunction in Alzheimer's disease
    Castellani, R
    Hirai, K
    Aliev, G
    Drew, KL
    Nunomura, A
    Takeda, A
    Cash, AD
    Obrenovich, ME
    Perry, G
    Smith, MA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 357 - 360
  • [22] Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium
    Singulani, Monique P.
    De Paula, Vanessa J. R.
    Forlenza, Orestes, V
    NEUROSCIENCE LETTERS, 2021, 760
  • [23] Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development
    Bhatia, Shiveena
    Rawal, Rishi
    Sharma, Pratibha
    Singh, Tanveer
    Singh, Manjinder
    Singh, Varinder
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (04) : 675 - 692
  • [24] Mitochondrial Dysfunction-A Pharmacological Target in Alzheimer's Disease
    Eckert, Gunter P.
    Renner, Kathrin
    Eckert, Schamim H.
    Eckmann, Janett
    Hagl, Stephanie
    Abdel-Kader, Reham M.
    Kurz, Christopher
    Leuner, Kristina
    Muller, Walter E.
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 136 - 150
  • [25] Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease
    Xue-Mei Gu
    Han-Chang Huang
    Zhao-Feng Jiang
    Neuroscience Bulletin, 2012, 28 : 631 - 640
  • [26] ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease
    Patro, Somya
    Ratna, Sujay
    Yamamoto, Hianny A.
    Ebenezer, Andrew T.
    Ferguson, Dillon S.
    Kaur, Amanpreet
    McIntyre, Brendan C.
    Snow, Ryan
    Solesio, Maria E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [27] Biological and genetic markers of sporadic Alzheimer's disease
    Engelborghs, S
    De Deyn, PP
    ACTA MEDICA OKAYAMA, 2001, 55 (02) : 55 - 63
  • [28] CoQ10 and Mitochondrial Dysfunction in Alzheimer's Disease
    Fisar, Zdenek
    Hroudova, Jana
    ANTIOXIDANTS, 2024, 13 (02)
  • [29] Mitochondrial aging and dysfunction in Alzheimer's disease
    Sullivan, PG
    Brown, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (03) : 407 - 410
  • [30] Mitochondrial genome lesions in the pathogenesis of sporadic Alzheimer's disease
    Meier-Ruge, WA
    Bertoni-Freddari, C
    GERONTOLOGY, 1999, 45 (05) : 289 - 297